Long-acting injection a shot in the arm for GSK`s HIV business
(Reuters Business)

A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker`s key HIV business.